nivolumab,etigilimab
mereo biopharmaceuticalceutical,bms,marker therapeutics
['biomarker', 'marker ', 'mereo ']
mereo biopharma reports clinical update and interim biomarker analysis presented at esmo 2022 from activate phase 1b 